{
    "doc_id": "v1_data/DeepSeek-V3_gpqa-diamond_responses_15.json",
    "metadata": {
        "model_id": "deepseek-ai/DeepSeek-V3",
        "correct_answer": "D"
    },
    "raw_text": {
        "question": "How many of the following compounds will exhibit optical activity?\n\n(Z)-1-chloro-2-methylbut-1-ene\n(3aR,7aS,E)-8-(chloromethylene)hexahydro-4,7-methanoisobenzofuran-1,3-dione\n(2R,3S)-2,3-dimethylsuccinic acid\n(2R,3R)-2,3-dimethylsuccinic acid\n(R)-cyclohex-3-en-1-ol\n(1s,3s,5s)-cyclohexane-1,3,5-triol\n1-cyclopentyl-3-methylbutan-1-one\nA. 4\nB. 2\nC. 5\nD. 3",
        "response": "To determine how many of the given compounds exhibit optical activity, we need to identify whether each compound has a chiral center (or centers) and whether the molecule as a whole is chiral. Optical activity arises from chirality, meaning the molecule cannot be superimposed on its mirror image.\n\nLet\u2019s analyze each compound:\n\n---\n\n1. **(Z)-1-chloro-2-methylbut-1-ene**  \n   - This compound has a double bond with substituents on the same side (Z-configuration).  \n   - It does not have a chiral center, so it is **not optically active**.\n\n---\n\n2. **(3aR,7aS,E)-8-(chloromethylene)hexahydro-4,7-methanoisobenzofuran-1,3-dione**  \n   - This compound has multiple stereocenters (3aR and 7aS) and an E-configuration around the double bond.  \n   - The presence of stereocenters makes it chiral, so it is **optically active**.\n\n---\n\n3. **(2R,3S)-2,3-dimethylsuccinic acid**  \n   - This compound has two stereocenters (2R and 3S).  \n   - The molecule is **meso** (internally symmetric) and superimposable on its mirror image, so it is **not optically active**.\n\n---\n\n4. **(2R,3R)-2,3-dimethylsuccinic acid**  \n   - This compound has two stereocenters (2R and 3R).  \n   - The molecule is chiral and **optically active**.\n\n---\n\n5. **(R)-cyclohex-3-en-1-ol**  \n   - This compound has one stereocenter (R-configuration).  \n   - It is chiral and **optically active**.\n\n---\n\n6. **(1s,3s,5s)-cyclohexane-1,3,5-triol**  \n   - This compound has three stereocenters (1s, 3s, 5s).  \n   - The molecule is **meso** (internally symmetric) and superimposable on its mirror image, so it is **not optically active**.\n\n---\n\n7. **1-cyclopentyl-3-methylbutan-1-one**  \n   - This compound does not have a chiral center, so it is **not optically active**.\n\n---\n\n### Summary of Optically Active Compounds:\n- Compound 2: Yes  \n- Compound 4: Yes  \n- Compound 5: Yes  \n\nTotal: **3**\n\n---\n\n**Answer:** D. 3"
    },
    "nodes": [
        {
            "id": "ctx0",
            "annotation": false,
            "start": 0,
            "end": 68,
            "label": "context",
            "text": "How many of the following compounds will exhibit optical activity?\n\n",
            "source": "question"
        },
        {
            "id": "ctx1",
            "annotation": false,
            "start": 68,
            "end": 338,
            "label": "context",
            "text": "(Z)-1-chloro-2-methylbut-1-ene\n(3aR,7aS,E)-8-(chloromethylene)hexahydro-4,7-methanoisobenzofuran-1,3-dione\n(2R,3S)-2,3-dimethylsuccinic acid\n(2R,3R)-2,3-dimethylsuccinic acid\n(R)-cyclohex-3-en-1-ol\n(1s,3s,5s)-cyclohexane-1,3,5-triol\n1-cyclopentyl-3-methylbutan-1-one\nA. ",
            "source": "question"
        },
        {
            "id": "ctx2",
            "annotation": false,
            "start": 338,
            "end": 343,
            "label": "context",
            "text": "4\nB. ",
            "source": "question"
        },
        {
            "id": "ctx3",
            "annotation": false,
            "start": 343,
            "end": 354,
            "label": "context",
            "text": "2\nC. 5\nD. 3",
            "source": "question"
        },
        {
            "id": "resp0",
            "annotation": false,
            "start": 0,
            "end": 193,
            "label": "planning",
            "text": "To determine how many of the given compounds exhibit optical activity, we need to identify whether each compound has a chiral center (or centers) and whether the molecule as a whole is chiral. ",
            "source": "response"
        },
        {
            "id": "resp1",
            "annotation": false,
            "start": 193,
            "end": 299,
            "label": "fact",
            "text": "Optical activity arises from chirality, meaning the molecule cannot be superimposed on its mirror image.\n\n",
            "source": "response"
        },
        {
            "id": "resp2",
            "annotation": false,
            "start": 299,
            "end": 329,
            "label": "planning",
            "text": "Let\u2019s analyze each compound:\n\n",
            "source": "response"
        },
        {
            "id": "resp3",
            "annotation": false,
            "start": 329,
            "end": 334,
            "label": "restatement",
            "text": "---\n\n",
            "source": "response"
        },
        {
            "id": "resp4",
            "annotation": false,
            "start": 334,
            "end": 467,
            "label": "fact",
            "text": "1. **(Z)-1-chloro-2-methylbut-1-ene**  \n   - This compound has a double bond with substituents on the same side (Z-configuration).  \n",
            "source": "response"
        },
        {
            "id": "resp5",
            "annotation": false,
            "start": 467,
            "end": 542,
            "label": "reasoning",
            "text": "   - It does not have a chiral center, so it is **not optically active**.\n\n",
            "source": "response"
        },
        {
            "id": "resp6",
            "annotation": false,
            "start": 542,
            "end": 547,
            "label": "restatement",
            "text": "---\n\n",
            "source": "response"
        },
        {
            "id": "resp7",
            "annotation": false,
            "start": 547,
            "end": 741,
            "label": "fact",
            "text": "2. **(3aR,7aS,E)-8-(chloromethylene)hexahydro-4,7-methanoisobenzofuran-1,3-dione**  \n   - This compound has multiple stereocenters (3aR and 7aS) and an E-configuration around the double bond.  \n",
            "source": "response"
        },
        {
            "id": "resp8",
            "annotation": false,
            "start": 741,
            "end": 825,
            "label": "reasoning",
            "text": "   - The presence of stereocenters makes it chiral, so it is **optically active**.\n\n",
            "source": "response"
        },
        {
            "id": "resp9",
            "annotation": false,
            "start": 825,
            "end": 830,
            "label": "restatement",
            "text": "---\n\n",
            "source": "response"
        },
        {
            "id": "resp10",
            "annotation": false,
            "start": 830,
            "end": 929,
            "label": "fact",
            "text": "3. **(2R,3S)-2,3-dimethylsuccinic acid**  \n   - This compound has two stereocenters (2R and 3S).  \n",
            "source": "response"
        },
        {
            "id": "resp11",
            "annotation": false,
            "start": 929,
            "end": 1058,
            "label": "reasoning",
            "text": "   - The molecule is **meso** (internally symmetric) and superimposable on its mirror image, so it is **not optically active**.\n\n",
            "source": "response"
        },
        {
            "id": "resp12",
            "annotation": false,
            "start": 1058,
            "end": 1063,
            "label": "restatement",
            "text": "---\n\n",
            "source": "response"
        },
        {
            "id": "resp13",
            "annotation": false,
            "start": 1063,
            "end": 1162,
            "label": "fact",
            "text": "4. **(2R,3R)-2,3-dimethylsuccinic acid**  \n   - This compound has two stereocenters (2R and 3R).  \n",
            "source": "response"
        },
        {
            "id": "resp14",
            "annotation": false,
            "start": 1162,
            "end": 1217,
            "label": "reasoning",
            "text": "   - The molecule is chiral and **optically active**.\n\n",
            "source": "response"
        },
        {
            "id": "resp15",
            "annotation": false,
            "start": 1217,
            "end": 1222,
            "label": "restatement",
            "text": "---\n\n",
            "source": "response"
        },
        {
            "id": "resp16",
            "annotation": false,
            "start": 1222,
            "end": 1315,
            "label": "fact",
            "text": "5. **(R)-cyclohex-3-en-1-ol**  \n   - This compound has one stereocenter (R-configuration).  \n",
            "source": "response"
        },
        {
            "id": "resp17",
            "annotation": false,
            "start": 1315,
            "end": 1360,
            "label": "reasoning",
            "text": "   - It is chiral and **optically active**.\n\n",
            "source": "response"
        },
        {
            "id": "resp18",
            "annotation": false,
            "start": 1360,
            "end": 1365,
            "label": "restatement",
            "text": "---\n\n",
            "source": "response"
        },
        {
            "id": "resp19",
            "annotation": false,
            "start": 1365,
            "end": 1468,
            "label": "fact",
            "text": "6. **(1s,3s,5s)-cyclohexane-1,3,5-triol**  \n   - This compound has three stereocenters (1s, 3s, 5s).  \n",
            "source": "response"
        },
        {
            "id": "resp20",
            "annotation": false,
            "start": 1468,
            "end": 1597,
            "label": "reasoning",
            "text": "   - The molecule is **meso** (internally symmetric) and superimposable on its mirror image, so it is **not optically active**.\n\n",
            "source": "response"
        },
        {
            "id": "resp21",
            "annotation": false,
            "start": 1597,
            "end": 1602,
            "label": "restatement",
            "text": "---\n\n",
            "source": "response"
        },
        {
            "id": "resp22",
            "annotation": false,
            "start": 1602,
            "end": 1731,
            "label": "reasoning",
            "text": "7. **1-cyclopentyl-3-methylbutan-1-one**  \n   - This compound does not have a chiral center, so it is **not optically active**.\n\n",
            "source": "response"
        },
        {
            "id": "resp23",
            "annotation": false,
            "start": 1731,
            "end": 1736,
            "label": "restatement",
            "text": "---\n\n",
            "source": "response"
        },
        {
            "id": "resp24",
            "annotation": false,
            "start": 1736,
            "end": 1840,
            "label": "restatement",
            "text": "### Summary of Optically Active Compounds:\n- Compound 2: Yes  \n- Compound 4: Yes  \n- Compound 5: Yes  \n\n",
            "source": "response"
        },
        {
            "id": "resp25",
            "annotation": false,
            "start": 1840,
            "end": 1854,
            "label": "reasoning",
            "text": "Total: **3**\n\n",
            "source": "response"
        },
        {
            "id": "resp26",
            "annotation": false,
            "start": 1854,
            "end": 1859,
            "label": "restatement",
            "text": "---\n\n",
            "source": "response"
        },
        {
            "id": "resp27",
            "annotation": false,
            "start": 1859,
            "end": 1875,
            "label": "conclusion",
            "text": "**Answer:** D. 3",
            "source": "response"
        }
    ],
    "edges": [
        {
            "id": "e0",
            "from_node_id": "resp0",
            "to_node_id": "resp1",
            "label": "reason:plan-step"
        },
        {
            "id": "e1",
            "from_node_id": "resp0",
            "to_node_id": "resp2",
            "label": "plan:plan-subplan"
        },
        {
            "id": "e2",
            "from_node_id": "resp1",
            "to_node_id": "resp2",
            "label": "plan:frontier-plan"
        },
        {
            "id": "e3",
            "from_node_id": "resp2",
            "to_node_id": "resp3",
            "label": "reason:plan-step"
        },
        {
            "id": "e4",
            "from_node_id": "resp2",
            "to_node_id": "resp4",
            "label": "reason:plan-step"
        },
        {
            "id": "e5",
            "from_node_id": "resp3",
            "to_node_id": "resp4",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e6",
            "from_node_id": "resp1",
            "to_node_id": "resp5",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e7",
            "from_node_id": "resp2",
            "to_node_id": "resp5",
            "label": "reason:plan-step"
        },
        {
            "id": "e8",
            "from_node_id": "resp4",
            "to_node_id": "resp5",
            "label": "reason:fact-detail"
        },
        {
            "id": "e9",
            "from_node_id": "resp3",
            "to_node_id": "resp6",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e10",
            "from_node_id": "resp6",
            "to_node_id": "resp7",
            "label": "reason:fact-detail"
        },
        {
            "id": "e11",
            "from_node_id": "resp7",
            "to_node_id": "resp8",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e12",
            "from_node_id": "resp8",
            "to_node_id": "resp9",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e13",
            "from_node_id": "resp2",
            "to_node_id": "resp10",
            "label": "reason:plan-step"
        },
        {
            "id": "e14",
            "from_node_id": "resp9",
            "to_node_id": "resp10",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e15",
            "from_node_id": "resp9",
            "to_node_id": "resp11",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e16",
            "from_node_id": "resp10",
            "to_node_id": "resp11",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e17",
            "from_node_id": "resp11",
            "to_node_id": "resp12",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e18",
            "from_node_id": "resp12",
            "to_node_id": "resp13",
            "label": "reason:fact-detail"
        },
        {
            "id": "e19",
            "from_node_id": "resp13",
            "to_node_id": "resp14",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e20",
            "from_node_id": "resp14",
            "to_node_id": "resp15",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e21",
            "from_node_id": "resp15",
            "to_node_id": "resp16",
            "label": "reason:fact-detail"
        },
        {
            "id": "e22",
            "from_node_id": "resp16",
            "to_node_id": "resp17",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e23",
            "from_node_id": "resp17",
            "to_node_id": "resp18",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e24",
            "from_node_id": "resp16",
            "to_node_id": "resp19",
            "label": "reason:fact-detail"
        },
        {
            "id": "e25",
            "from_node_id": "resp18",
            "to_node_id": "resp19",
            "label": "reason:plan-step"
        },
        {
            "id": "e26",
            "from_node_id": "resp19",
            "to_node_id": "resp20",
            "label": "reason:fact-detail"
        },
        {
            "id": "e27",
            "from_node_id": "resp20",
            "to_node_id": "resp20",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e28",
            "from_node_id": "resp20",
            "to_node_id": "resp21",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e29",
            "from_node_id": "resp2",
            "to_node_id": "resp22",
            "label": "reason:plan-step"
        },
        {
            "id": "e30",
            "from_node_id": "resp22",
            "to_node_id": "resp22",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e31",
            "from_node_id": "resp22",
            "to_node_id": "resp23",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e32",
            "from_node_id": "resp2",
            "to_node_id": "resp24",
            "label": "reason:plan-step"
        },
        {
            "id": "e33",
            "from_node_id": "resp8",
            "to_node_id": "resp24",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e34",
            "from_node_id": "resp14",
            "to_node_id": "resp24",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e35",
            "from_node_id": "resp17",
            "to_node_id": "resp24",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e36",
            "from_node_id": "resp24",
            "to_node_id": "resp25",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e37",
            "from_node_id": "resp25",
            "to_node_id": "resp26",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e38",
            "from_node_id": "resp24",
            "to_node_id": "resp27",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e39",
            "from_node_id": "resp25",
            "to_node_id": "resp27",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e40",
            "from_node_id": "resp26",
            "to_node_id": "resp27",
            "label": "reason:plan-step"
        }
    ]
}